Core CSF biomarkers including total (T-Tau) and phosphorylated Tau (P-Tau) protein, Aβ42, and neurofilament light polypeptide have been strongly associated with AD, such that their clinical implementation for diagnostic purposes has been suggested [61]. The gene discussed is MAPT; the disease is Alzheimer disease.